Medicine

The gut microbiota, obesity and insulin resistance

The gut microbiota, obesity and insulin resistance

The gut microbiota, obesity and insulin resistance

Abstract

Due to the rapidly expanding prevalence of obesity, bariatric surgery is becoming an increasingly popular treatment option. Bariatric surgeries including Roux-en-Y gastric
bypass (RYGB) and vertical sleeve gastrectomy (VSG) produce long-term weight loss and
metabolic improvement, reducing mortality. This review discusses the important benefits
and risks of RYGB and VSG, highlighting hypothesized mechanisms for these effects. We
present data suggesting that VSG, albeit a newer procedure, may be as effective as RYGB
with fewer adverse effects including less surgical risk, reduced nutritional deficiency,
and less incidence of dumping syndrome. This may position VSG as an increasingly impor-
tant procedure, particularly for the treatment of pediatric obesity.

 

read online

Post Comment